publication date: Sep. 11, 2020

In Brief

Mays Cancer Center receives renewal of NCI designation

Mays Cancer Center has received a renewal of its NCI-designation for the next five years.

The renewal comes after 18 months of preparation across Mays Cancer Center and the UT Health San Antonio divisions, departments and schools. On Sept. 25, 2019, the center submitted its renewal grant, which was more than 1,000 pages long.

The NCI-designated cancer center program celebrates 50 years in 2021. It was established as part of the National Cancer Act of 1971. Mays Cancer Center was founded in 1974 and has been an NCI-designated cancer center since 1991.

On Feb. 25, 2020, Mays Cancer Center completed its in-person site visit with more than 20 visitors from other NCI cancer centers and representatives from NCI.

A summary of their review follows:

Mays Cancer Center has emerging research programs supported by strong shared resources, energized clinical research infrastructure and solid educational programs. Clear cancer focus is evident and basic discoveries are being moved through the translational pipeline.

A major strength of the center is the profound commitment shown to the needs of its catchment area, which has a predominantly Hispanic population. While accruals to clinical trials are improving, further attention is needed. Increased investments in research infrastructure, strong program leadership and robust institutional support indicate a center on an upward trajectory.



Justin Leung receives $1.9 million in funds to research DNA damage response

Justin Leung, of University of Arkansas for Medical Sciences, has received a $1.9 million grant from the National … Continue reading Mays Cancer Center receives renewal of NCI designation

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.